Management of Pulmonary Arterial Hypertension with Sitaxentan Sodium

Pulmonary arterial hypertension (PAH) is a chronic and progressive disease with a poor prognosis if left untreated. Pathophysiological alterations in this disease lead to vasoconstriction, endothelial and smooth muscle cell proliferation, and in situ thrombosis. Endothelin-1 (one of the most potent...

Full description

Saved in:
Bibliographic Details
Published inClinical Medicine Insights: Therapeutics Vol. 2011; no. 3; pp. 31 - 38
Main Authors Pulido, Tomas, Murillo, Carla, Ramírez-Neria, Paulina, Hurtado, Viridiana, de la Garza, Paola, Astorga, Sandra, Miranda, María Teresa, Sandoval, Julio
Format Journal Article Book Review
LanguageEnglish
Published London, England Libertas Academica 01.01.2011
SAGE Publishing
SAGE Publications
Sage Publications Ltd
Subjects
Online AccessGet full text

Cover

Loading…